CS
Chan Sing En
About Chan Sing En
Data last updated:
Chan Sing En is a Director at Fischer Medical Ventures Limited (since 2025), Additional Director at Time Medical International Ventures (India) Private Limited (since 2025) and Additional Director at Flynncare Health Innovations Private Limited (since 2025). The companies operate in Chemicals and Materials and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹432 Cr; the largest is Fischer Medical Ventures Limited at ₹321 Cr (FY 2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fischer Medical Ventures Limited L86900AP1993PLC118162 | Director | 28 Oct 2025 | 1993 | ₹321 Cr (FY 2026) | Active |
 Time Medical International Ventures (India) Private Limited U74999TN2019PTC126835 | Additional Director | 28 Oct 2025 | 2019 | ₹83.89 Cr (FY 2025) | Active |
| Flynncare Health Innovations Private Limited U86100TN2024PTC172323 | Additional Director | 28 Oct 2025 | 2024 | ₹27.43 Cr (FY 2025) | Active |
Board colleagues of Chan Sing En
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chan Sing En
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chan Sing En
Chan Sing En currently holds 3 directorships: Fischer Medical Ventures Limited (Director, since 28 Oct 2025, revenue ₹321 Cr (FY 2026)); Time Medical International Ventures (India) Private Limited (Additional Director, since 28 Oct 2025, revenue ₹83.89 Cr (FY 2025)); Flynncare Health Innovations Private Limited (Additional Director, since 28 Oct 2025, revenue ₹27.43 Cr (FY 2025)).
Chan Sing En was first appointed on 28 Oct 2025 as Director at Fischer Medical Ventures Limited.
The 3 current companies of Chan Sing En that report revenue have a combined latest revenue of ₹432 Cr: Fischer Medical Ventures Limited ₹321 Cr (FY 2026); Time Medical International Ventures (India) Private Limited ₹83.89 Cr (FY 2025); Flynncare Health Innovations Private Limited ₹27.43 Cr (FY 2025).
The current boards of Chan Sing En's companies include Balaji Gandla (Fischer Medical Ventures Limited), David Yeow Kok Hee (Fischer Medical Ventures Limited), Jaya Ankur Singhania (Fischer Medical Ventures Limited), Khairy Jamaluddin Abu Bakar (Fischer Medical Ventures Limited), Ravindran Govindan (Fischer Medical Ventures Limited), Svetlana Rao Raviwada (Fischer Medical Ventures Limited), among others.